中康科技控股2025年度报告

Contents 2Corporate Information5Financial Summary6Chairman’s Statement11Management Discussion and Analysis54Directors and Senior Management62Directors’ Report104Corporate Governance Report125Environmental, Social and Governance Report199Independent Auditor’s Report210Consolidated Statement of Profit or Lossand Other Comprehensive Income211Consolidated Statement of Financial Position213Consolidated Statement of Changes in Equity215Consolidated Statement of Cash Flows219Notes to Financial Statements360Definitions 2CORPORATE INFORMATION BOARD OF DIRECTORSExecutive DirectorsMr. Wu Yushu(Chairman)Ms. Wang Lifang Non-executive DirectorMr. Fu Haitao Independent Non-executive Directors Ms. Wang DanzhouMs. Chui Hoi YamMr. Wei Bin AUDIT COMMITTEE Mr. Wei Bin(Chairman)Ms. Wang DanzhouMs. Chui Hoi Yam REMUNERATION COMMITTEE Ms. Wang Danzhou(Chairperson)Ms. Chui Hoi YamMs. Wang Lifang NOMINATION COMMITTEE Mr. Wu Yushu(Chairman)Ms. Chui Hoi YamMs. Wang Danzhou AUTHORISED REPRESENTATIVES Mr. Wu YushuMs. Zhang Xiao COMPANY SECRETARYMs. Zhang Xiao ACG, HKACG ACGHKACG REGISTERED OFFICE IN THE CAYMAN ISLANDS 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands 89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands PRINCIPAL PLACE OF BUSINESS IN THE PRC 51111 Room 1111, No.5 Wangjiang Second StreetHuangge Town, Nansha DistrictGuangzhou CityGuangdong ProvincePRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 1357732 Room 732, 7th Floor, Rykadan Tower135 Hoi Bun Road, Kwun TongKowloonHong Kong CAYMAN ISLANDS PRINCIPAL SHAREREGISTRAR AND TRANSFER OFFICE Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands Ogier Global (Cayman) Limited89 Nexus WayCamana BayGrand Cayman KY1-9009Cayman Islands HONG KONG SHARE REGISTRAR ANDTRANSFER OFFICE 148212103B Boardroom Share Registrars (HK) Limited2103B, 21/F148 Electric RoadNorth PointHong Kong 4CORPORATE INFORMATION LEGAL ADVISERS 15323203-3209 As to Hong Kong lawJingtian & Gongcheng LLPSuites 3203-320932/F, Edinburgh TowerThe Landmark15 Queen’s Road CentralHong Kong 101045 As to PRC lawJingtian & Gongcheng45/F, K.Wah Centre1010 Huaihai Road (M)ShanghaiChina AUDITOR 979127 Ernst& YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong PRINCIPAL BANKS 76 Ping An Bank Guangzhou Huangpu Avenue Branch1/F, Fulilong SquareNo. 76 Huangpu Avenue WestTianhe DistrictGuangzhou CityGuangdong ProvincePRC STOCK CODE 23612361 ir.sinohealth.cn Sinohealth Technology Holdings Limited2025 ANNUAL REPORT 2022202320242025123120222023202420211231 The following is a summary of the Group’s published resultsand assets and liabilities for the past five financial years. Thefinancial information for the years ended 31 December 2022,2023, 2024 and 2025 is extracted from the consolidatedfinancial statements of 2022, 2023, 2024 and this annualreport, and the financial information for the year ended 31December 2021 is extracted from the Prospectus. (i)(ii)(iii)(iv) 1Operating profit is defined as gross profit less (i) selling anddistribution expenses; (ii) administrative expenses; (iii) research anddevelopment costs; and (iv) net impairment loss on financial assets. 6CHAIRMAN’S STATEMENT 2025 Looking back at 2025, despite the complex global macroenvironment, breakthroughs and widespread application ofartificial intelligence technology emerged as the core forcedriving transformation across all industries. The strategicimportance of the healthcare industry in national economicdevelopment has been increasingly prominent. Driven by bothnational policy guidance and technological innovation, theindustry’s digital transformation process has been acceleratedcomprehensively, while the value of data as a key productionfactor has been continuously unleashed, providing cleardirection and vast opportunities for the Group to leverage itsdeep data resources and industrial accumulation to achieveservice upgrades and strategic expansion. AIAI Over the past year, grounded in profound insights intoindustry trends, the Group formally elevated its strategicpositioning to become an “comprehensive AI technologyservices company based on the data assets and ecologicalresources of the healthcare industry”. This marks the entryinto a new phase where AI technology comprehensivelydrives business operations and reconstructs value. This isnot a passive business transformation, but rather a proactivestrategic elevation based on the solid foundation accumulatedover the past eighteen years in data, resources and insights ofthe healthcare industry. DEEPENING AI STRATEGY TO CONSOLIDATEDEVELOPMENT FOUNDATIONAI 2025AIAI(Agent)AIAI I n 2 0 2 5 , t h e G r o u p c o n c e n t r a t e d i t s r e s o u r c e s o ncomprehensive investment in AI technology R&D, businessintegration, and organizational capability building, achievingsubstantial progress in key areas. This marks the Company’sformal stra